Page 17 - ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி Today - Breaking & Trending Today

Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial


1
: Synairgen plc (LSE: SNG), the respiratory company developing inhaled interferon beta (IFN-beta) for the treatment of severe viral lung infections, today announces results from the Home Cohort of its SG016 Phase II trial of SNG001 in SARS-CoV-2 infected patients and data from the combined analysis of the Hospital and Home Cohorts.
SNG001 is a formulation containing IFN-beta for nebulisation, allowing it to be delivered directly into patients’ lungs. A number of studies have reported that the SARS-CoV-2 virus suppresses natural production of IFN-beta and prevents induction of anti-viral responses by infected cells. Furthermore, some people have deficiencies in antiviral IFN signalling that make them more vulnerable to spread of the virus from the nose into the lungs where it can cause severe breathing difficulties. These findings provide a rationale to deliver IFN-beta directly to the surface epithelial cells of the lungs, the primary site of virus infection in the lun ....

United Kingdom , Olivia Manser , Geoff Nash , Mary Conway , Nick Francis , Richard Marsden , John Ward , Tom Wilkinson , Donna Davies , Duncan Monteith , Jessica Hodgson , James Black , Kate Bannatyne , Ratko Djukanovic , Mary Jane Elliott , Freddie Barnfield , Numis Securities Limited Joint Broker , University Of Southampton , United Kingdom National Institute For Health Research , Drug Administration , Consilium Strategic Communications Financial Media , National Institute For Health Research , University Of Southampton Professors Sir Stephen Holgate , Urgent Public Health , Foundation Trust Southampton , University Hospital Southampton ,

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

France Vs UK COVID-19 Vaccine Immunogenicity Show-Down


April 21, 2021 • 3:52 pm CDT
(Precision Vaccinations)
France-based Valneva SE announced it had initiated a pivotal Phase 3 clinical trial for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
The Phase 3 trial, “Cov-Compare” (VLA2001-301), will compare VLA2001 against AstraZeneca’s COVID-19 conditionally approved vaccine, known as Vaxzevria in a comparative immunogenicity trial. Approximately 4,000 participants located in the United Kingdom (UK) will receive two doses of either vaccine administered in a four-week interval.
The primary endpoint of Cov-Compare will be to determine the immune response (Geometric Mean Titer (GMT)) of SARS-CoV-2-specific neutralizing antibodies) two weeks after immunization. The trial is powered to demonstrate the superiority of VLA2001 in terms of GMT ratio (VLA2001/Vaxzevria). ....

United Kingdom , Nadhim Zahawi , United Kingdom National Institute For Health Research , Precision Vaccinations , Geometric Mean Titer , United Kingdom Minister , National Institute , France Based Valneva , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி , ப்ரிஸிஶந் தடுப்பூசிகள் , ஒன்றுபட்டது கிஂக்டம் அமைச்சர் , தேசிய நிறுவனம் ,

Leadership in the Digital Enterprise podcast: Tips from a Digital Trailblazer


Sam Lisco
It’s true that we learn from our mistakes, but given the choice, wouldn’t we all prefer to learn from the mistakes –
and the achievements – of others.
Samantha Liscio, 2020 Canadian CIO of the Year (public sector), makes a powerful case for vicarious learning as a guest on ITWC’s podcast series,
Series host, ITWC CIO Jim Love, opens the 45-minute podcast with an introduction to Liscio, former Chief Technology and Innovation Officer for Ontario’s Workplace Safety and Insurance Board, and incoming Chief Information and Technology Officer for the UK’s National Institute for Health Research (NIHR) Clinical Research Network (CRN). A digital transformation specialist with 20 years of experience in IT leadership roles, she comes to the table with a deep love of technology and a personal playbook for success.  ....

United Kingdom , Jim Love , Samantha Liscio , Samantha Liscio Sam Lisco , United Kingdom National Institute For Health Research , Clinical Research Network , Chief Technology , Innovation Officer , Workplace Safety , Insurance Board , Chief Information , Technology Officer , National Institute , Health Research , ஒன்றுபட்டது கிஂக்டம் , ஜிம் காதல் , ஒன்றுபட்டது கிஂக்டம் தேசிய நிறுவனம் க்கு ஆரோக்கியம் ஆராய்ச்சி , மருத்துவ ஆராய்ச்சி வலைப்பின்னல் , தலைமை தொழில்நுட்பம் , கண்டுபிடிப்பு அதிகாரி , பணியிடம் பாதுகாப்பு , காப்பீடு பலகை , தலைமை தகவல் , தொழில்நுட்பம் அதிகாரி , தேசிய நிறுவனம் , ஆரோக்கியம் ஆராய்ச்சி ,